Stage III Gastric Adenocarcinoma: Harrison's Survivor Story

Patient Info: Harrison | Stage III

Several years after diagnosis, Harrison described being in remission while continuing to fear that the gastric cancer could return.

Our Cancer StoriesRead more →

Metastatic Breast Cancer With Liver Progression Treated Through Multiple Chemotherapy Lines

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: Initial tumor: ER 90%, HER2 3+, Ki67 15%. Liver metastasis: ER 30%

Metastatic Site: pleura, liver

After several periods of response and later liver progression, she remained on active treatment with pegylated liposomal doxorubicin.

PubMed CentralRead more →

Metastatic Lobular Breast Cancer With Long-Term Disease Control Across Multiple Therapies

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: Initial tumor: ER negative, HER2 negative, Ki67 17%. 2006 recurrence: ER 40%

Metastatic Site: pleura, liver, skin, bone

She was alive on ongoing metronomic vinorelbine with substantial disease stabilization at the most recent follow-up.

PubMed CentralRead more →

Stage II Breast Cancer: Ana's Survivor Story

Patient Info: Ana, Female, 50s | Stage II

Ana reported being declared cancer-free in March 2020 and continued hormone therapy afterward, with no recurrence described in the available story.

Our Cancer StoriesRead more →

Metastatic Breast Cancer With Bone and Liver Progression After Multiple Therapies

Patient Info: Anonymized, female, Under 40 | Stage IV

Biomarkers: Initial tumor: ER 80%, HER2 negative, Ki67 18%. Liver metastasis: ER 75%

Metastatic Site: bone, liver

After massive hepatic progression and liver failure, chemotherapy was stopped and she died on January 31, 2016.

PubMed CentralRead more →

Bilateral Breast Cancers Followed by Metastatic Disease and Long Eribulin Treatment

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: Left primary: ER 90%, HER2 FISH not amplified, Ki67 25%. Right primary: ER 90%

Metastatic Site: lung, pleura, liver, bone

After pelvic bone metastases appeared in 2017, she stopped eribulin, received pelvic radiation and remained on fulvestrant treatment.

PubMed CentralRead more →

Breast Cancer: Tonya's Survivor Story

Patient Info: Tonya, Female

Tonya said she was in remission while continuing radiation therapy and hormone therapy.

Our Cancer StoriesRead more →

Recurrent Breast Cancer With Liver Metastases Treated Through Multiple Chemotherapy Lines

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: Initial tumor: ER positive, HER2 0. Liver metastasis: ER 100%

Metastatic Site: liver

After liver progression following 18 cycles of eribulin, she started weekly carboplatin and remained in active treatment.

PubMed CentralRead more →

Metastatic Breast Cancer With Durable Liver and Peritoneal Response to Eribulin

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: Initial tumor: ER 90%, PgR 70%. Liver metastasis: ER 60%, HER2 1+

Metastatic Site: liver, peritoneum

While continuing eribulin beyond 34 cycles, her liver disease was stable and the peritoneal response persisted after earlier major tumor reduction.

PubMed CentralRead more →

Stage III Breast Cancer: Jacquelyn's Patient Story

Patient Info: Jacquelyn | Stage III

Jacquelyn said her stage 3 breast cancer was in remission while hormone therapy medication continued after mastectomy, chemotherapy, and radiation.

Our Cancer StoriesRead more →

Metastatic Breast Cancer Responding to Eribulin After Repeated Liver Progression

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: ER 100%, HER2 negative

Metastatic Site: bone, liver

Eribulin remained ongoing with repeated partial responses documented through 12 cycles and no need for dose reduction.

PubMed CentralRead more →

HER2-Positive Recurrent Breast Cancer Treated With Multiple Targeted and Local Therapies

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: 2008 recurrence: ER 80%, HER2 FISH amplified. 2011 recurrence: ER 80%

Metastatic Site: liver, skin

After 25 cycles of eribulin, treatment was still ongoing; nodal disease remained stable, while later imaging also noted new metabolic activity in the upper lung.

PubMed CentralRead more →

Metastatic Breast Cancer With Brain, Bone, Lung and Liver Disease Responding During Eribulin Treatment

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: Initial tumor: ER 90%, HER2 negative, Ki67 10%. Lung metastasis: ER 90%

Metastatic Site: lung, bone, brain, liver

Eribulin remained ongoing with reduced brain lesions, stable bone disease and continued shrinkage of liver metastases after prior systemic progression.

PubMed CentralRead more →

Stage I Breast Cancer: Yanzi's Patient Story

Patient Info: Yanzi, 40s | Stage I

Years after her Stage I diagnosis, Yanzi had completed the other treatment and remained on hormone medication while coping with fear of recurrence.

Our Cancer StoriesRead more →

Stage IV Colorectal Adenocarcinoma: Patricia's Patient Story

Patient Info: Patricia, 50s | Stage IV

Living with Stage IV colorectal cancer after about 6.5 years of intermittent chemotherapy and multiple local treatments; on a treatment holiday while awaiting December 2024 scans.

Our Cancer StoriesRead more →

Stage II gastric adenocarcinoma diagnosed at the same time as Hodgkin lymphoma

Patient Info: Anonymized, Male, 40s | Stage II

Biomarkers: HER2 IHC 0

Routine follow-up was ongoing as of November 2016.

PubMed CentralRead more →

Metastatic gastric cancer returns about 5 years after treatment and causes pulmonary tumor thrombotic microangiopathy

Patient Info: Anonymized, Male, 60s | Stage IV

Metastatic Site: bone marrow; pulmonary microvasculature

He died of respiratory failure from pulmonary tumor thrombotic microangiopathy on hospital day 45, about 5 years after his initial gastric cancer diagnosis.

PubMed CentralRead more →

Breast cancer returning 21 years later as a solitary parotid metastasis

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: Parotid metastasis ER positive; PR positive; HER2 borderline by IHC but FISH 1.82

Metastatic Site: left parotid gland

More than 5 months after the parotid metastasis was diagnosed, the tumour had slightly decreased in size and her metastatic disease remained stable on endocrine therapy.

PubMed CentralRead more →

Gastric Cancer: Do's Survivor Story

Patient Info: Do Lee, Male, 70+

He had shown no evidence of disease since October 2017.

MD AndersonRead more →

Stage IV rectal cancer treatment complicated by repeated heart-related side effects

Patient Info: Anonymized, Female | Stage IV

Biomarkers: p53 mutation

Metastatic Site: liver

After responding again to adapted chemotherapy and NanoKnife ablation, she had no evidence of active disease and had not restarted chemotherapy; ileostomy reversal was planned.

PubMed CentralRead more →

Metastatic gastric cancer recurs 12 years after gastrectomy and severe hypocalcemia follows denosumab

Patient Info: Anonymized, Female, 70+ | Stage IV

Metastatic Site: pleura

She died 68 days after receiving denosumab during progressive recurrent disease, roughly 12 years after her original gastric cancer surgery.

PubMed CentralRead more →

Five Years Without Recurrence After Surgery and Gamma Knife for a Cerebellar Metastasis From EGJ Cancer

Patient Info: Anonymized, female, 70+ | Stage IV

Biomarkers: CK7 negative, CK20 positive

Metastatic Site: cerebellum

Five years after removal of the cerebellar metastasis and Gamma Knife radiosurgery, she was asymptomatic with no evidence of recurrence.

PubMed CentralRead more →

Fundic-gland-type gastric adenocarcinoma treated by endoscopic resection in a man with multiple gastric cancers

Patient Info: Anonymized, Male, 50s

No residual fundic-gland-type adenocarcinoma was found around the endoscopic resection scar in the later gastrectomy specimen.

PubMed CentralRead more →

Antral gastric adenocarcinoma treated with total gastrectomy in a man with multiple gastric cancers

Patient Info: Anonymized, Male, 50s

A 58-year-old man with a separate small fundic-gland-type tumor also had a larger antral gastric adenocarcinoma that required total gastrectomy.

PubMed CentralRead more →